BIOMAT Database Logo BIOMAT Database Logo

Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients. 2015

I Wertel, and J Surówka, and G Polak, and B Barczyński, and W Bednarek, and J Jakubowicz-Gil, and A Bojarska-Junak, and J Kotarski
I Chair and Department of Oncological Gynaecology and Gynaecology, Medical University of Lublin, Staszica 16, 20-081, Lublin, Poland, iwonawertel@wp.pl.

The study was undertaken to evaluate macrophage-derived chemokine (CCL22) levels in the peritoneal fluid (PF) and plasma of patients with ovarian cancer (n = 93) in relation to regulatory T cells (Tregs; n = 75). The peritoneal fluid CCL22 concentrations were significantly higher in epithelial ovarian cancer (EOC) patients than in patients with benign tumors-serous cystadenoma (n = 32). There was no difference in plasma levels of CCL22 in EOC patients compared with the non-cancer and healthy volunteers (n = 10). There were no significant differences in the plasma and PF CCL22 levels based on tumor grade. However, women with stage IV FIGO (International Federation of Gynecologists and Obstetricians) had significantly higher plasma CCL22 levels than patients with stages I and III. Women with stage I FIGO had significantly higher PF CCL22 levels than patients with stages II and III. Women with endometrioid cystadenocarcinoma had higher PF CCL22 levels than women with undifferentiated carcinoma. The percentage of tumor-infiltrating Tregs (11.06 %) was significantly higher compared to PF (3.05 %) and peripheral blood (PB) (2.01 %). Moreover, the percentage of Tregs was higher in the PF than in the PB of EOC patients. There were no significant differences in the PB, PF, and tumor-infiltrating Tregs percentage based on tumor stage, grade, or histology. Elevated levels of CCL22 found in the ascites could create a chemokine gradient aiding in Treg cells migration. Increased Tregs percentage in the local microenvironment of ovarian cancer might be an important mechanism of immunosuppression.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

I Wertel, and J Surówka, and G Polak, and B Barczyński, and W Bednarek, and J Jakubowicz-Gil, and A Bojarska-Junak, and J Kotarski
Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancer.
November 2006, Cancer immunology, immunotherapy : CII,
I Wertel, and J Surówka, and G Polak, and B Barczyński, and W Bednarek, and J Jakubowicz-Gil, and A Bojarska-Junak, and J Kotarski
Regulation of macrophage-derived chemokine (MDC, CCL22) production.
January 2002, Critical reviews in immunology,
I Wertel, and J Surówka, and G Polak, and B Barczyński, and W Bednarek, and J Jakubowicz-Gil, and A Bojarska-Junak, and J Kotarski
The role of CCL22/macrophage-derived chemokine in allergic rhinitis.
December 2007, Clinical immunology (Orlando, Fla.),
I Wertel, and J Surówka, and G Polak, and B Barczyński, and W Bednarek, and J Jakubowicz-Gil, and A Bojarska-Junak, and J Kotarski
Mechanism of Macrophage-Derived Chemokine/CCL22 Production by HaCaT Keratinocytes.
April 2015, Annals of dermatology,
I Wertel, and J Surówka, and G Polak, and B Barczyński, and W Bednarek, and J Jakubowicz-Gil, and A Bojarska-Junak, and J Kotarski
Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells.
January 2016, Oncoimmunology,
I Wertel, and J Surówka, and G Polak, and B Barczyński, and W Bednarek, and J Jakubowicz-Gil, and A Bojarska-Junak, and J Kotarski
Macrophage-Derived Chemokine MDC/CCL22: An Ambiguous Finding in COVID-19.
August 2023, International journal of molecular sciences,
I Wertel, and J Surówka, and G Polak, and B Barczyński, and W Bednarek, and J Jakubowicz-Gil, and A Bojarska-Junak, and J Kotarski
Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo.
March 2001, European journal of immunology,
I Wertel, and J Surówka, and G Polak, and B Barczyński, and W Bednarek, and J Jakubowicz-Gil, and A Bojarska-Junak, and J Kotarski
Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis.
August 2009, Respiratory research,
I Wertel, and J Surówka, and G Polak, and B Barczyński, and W Bednarek, and J Jakubowicz-Gil, and A Bojarska-Junak, and J Kotarski
Overproduction of IgE induces macrophage-derived chemokine (CCL22) secretion from basophils.
October 2008, Journal of immunology (Baltimore, Md. : 1950),
I Wertel, and J Surówka, and G Polak, and B Barczyński, and W Bednarek, and J Jakubowicz-Gil, and A Bojarska-Junak, and J Kotarski
Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis.
November 2006, Journal of dermatological science,
Copied contents to your clipboard!